Shinpoong Pharmaceutical Co.,Ltd (KRX: 019170)

Shinpoong Pharmaceutical Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	50,115	43,800	41,691	27,637	55,803	23,374
Short-Term Investments	11,938	16,245	14,226	64,599	122,872	25,289
Trading Asset Securities	-	535.69	-	465.97	11,965	17,499
Cash & Short-Term Investments	62,053	60,581	55,917	92,702	190,639	66,162
Cash Growth	-18.30%	8.34%	-39.68%	-51.37%	188.14%	-0.64%
Accounts Receivable	70,822	73,661	82,289	81,865	88,671	99,356
Other Receivables	3,324	8,083	8,081	7,860	7,908	7,900
Receivables	74,362	81,945	90,576	89,925	96,779	107,536
Inventory	54,401	53,923	46,895	47,707	49,088	49,026
Prepaid Expenses	1,205	766.58	1,008	900.48	895.93	874.06
Other Current Assets	1,743	1,719	2,147	1,764	1,174	1,358
Total Current Assets	193,765	198,935	196,542	232,997	338,577	224,957
Property, Plant & Equipment	115,654	118,638	113,760	116,884	124,177	130,942
Long-Term Investments	21,159	21,107	29,336	28,571	14,876	12,641
Other Intangible Assets	5,239	5,769	6,931	8,971	8,062	8,914
Long-Term Deferred Tax Assets	-691.97	475.25	6,628	9,086	5,394	6,621
Other Long-Term Assets	2,357	5,159	8,339	1,841	1,829	1,803
Total Assets	337,482	350,084	361,536	398,350	492,915	385,879
Accounts Payable	9,589	8,941	11,428	12,060	8,789	18,373
Accrued Expenses	7,291	13,856	7,300	7,057	4,953	4,772
Short-Term Debt	41,500	45,000	-	248.11	150.17	98,507
Current Portion of Leases	919.27	932.48	1,487	719.94	1,059	320.19
Current Income Taxes Payable	7.36	118.11	-	133.02	59,467	74.3
Other Current Liabilities	7,108	7,537	6,952	8,332	8,919	11,907
Total Current Liabilities	66,414	76,385	27,167	28,550	83,337	133,953
Long-Term Debt	-	-	-	-	-	7,550
Long-Term Leases	377.26	218.96	441.51	212.67	575.85	113.62
Other Long-Term Liabilities	2,520	2,698	3,169	2,197	2,341	2,251
Total Liabilities	69,311	79,301	30,778	38,025	112,820	170,985
Common Stock	27,592	27,592	27,592	27,592	27,592	27,592
Additional Paid-In Capital	213,592	213,592	213,592	213,592	213,592	57,775
Retained Earnings	52,583	55,331	115,830	144,925	162,361	152,228
Treasury Stock	-8,734	-8,734	-8,734	-8,734	-8,734	-11,688
Comprehensive Income & Other	-18,132	-18,196	-18,673	-18,118	-15,675	-11,958
Total Common Equity	266,901	269,586	329,607	359,257	379,137	213,949
Minority Interest	1,270	1,196	1,151	1,067	958.76	944.57
Shareholders' Equity	268,171	270,782	330,758	360,324	380,095	214,893
Total Liabilities & Equity	337,482	350,084	361,536	398,350	492,915	385,879
Total Debt	42,797	46,151	1,928	1,181	1,785	106,491
Net Cash (Debt)	19,256	14,430	53,988	91,521	188,854	-40,328
Net Cash Growth	-34.67%	-73.27%	-41.01%	-51.54%	-	-
Net Cash Per Share	375.64	281.49	1053.18	1785.35	3752.42	-807.00
Filing Date Shares Outstanding	51.26	51.26	49.27	49.27	49.27	49.97
Total Common Shares Outstanding	51.26	51.26	51.26	51.26	51.26	49.97
Working Capital	127,350	122,550	169,375	204,447	255,240	91,003
Book Value Per Share	5206.58	5258.95	6429.82	7008.22	7396.02	4281.31
Tangible Book Value	261,662	263,817	322,676	350,286	371,075	205,035
Tangible Book Value Per Share	5104.38	5146.41	6294.62	6833.22	7238.75	4102.93
Land	15,976	15,976	15,976	15,976	15,976	15,976
Buildings	121,315	120,117	121,946	123,266	120,809	120,615
Machinery	109,980	103,969	104,000	104,224	98,806	110,389
Construction In Progress	1,751	5,426	4,231	329.3	4,974	3,529

Source: S&P Capital IQ. Standard template. Financial Sources.